Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.
Messahel B, Williams R, Ridolfi A, A'hern R, Warren W, Tinworth L, Hobson R, Al-Saadi R, Whyman G, Brundler MA, Kelsey A, Sebire N, Jones C, Vujanic G, Pritchard-Jones K; Children's Cancer and Leukaemia Group (CCLG). Messahel B, et al. Among authors: kelsey a, a hern r. Eur J Cancer. 2009 Mar;45(5):819-26. doi: 10.1016/j.ejca.2009.01.005. Epub 2009 Feb 21. Eur J Cancer. 2009. PMID: 19231157 Clinical Trial.
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
Anderson J, Gordon T, McManus A, Mapp T, Gould S, Kelsey A, McDowell H, Pinkerton R, Shipley J, Pritchard-Jones K; UK Children's Cancer Study Group (UKCCSG) and the UK Cancer Cytogenetics Group. Anderson J, et al. Among authors: kelsey a. Br J Cancer. 2001 Sep 14;85(6):831-5. doi: 10.1054/bjoc.2001.2008. Br J Cancer. 2001. PMID: 11556833 Free PMC article.
Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
Pritchard-Jones K, Kelsey A, Vujanic G, Imeson J, Hutton C, Mitchell C; United Kingdom Children's Cancer Study Group; Wilm's Tumor Working Group. Pritchard-Jones K, et al. Among authors: kelsey a. J Clin Oncol. 2003 Sep 1;21(17):3269-75. doi: 10.1200/JCO.2003.01.062. J Clin Oncol. 2003. PMID: 12947062 Clinical Trial.
Where to next with extracranial rhabdoid tumours in children.
Brennan BM, Foot AB, Stiller C, Kelsey A, Vujanic G, Grundy R, Pritchard Jones K; United Kingdom Children's Cancer Study Group (UKCCSG). Brennan BM, et al. Among authors: kelsey a. Eur J Cancer. 2004 Mar;40(4):624-6. doi: 10.1016/j.ejca.2003.11.014. Eur J Cancer. 2004. PMID: 14962734 No abstract available.
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
Grundy RG, Hutton C, Middleton H, Imeson J, Pritchard J, Kelsey A, Marsden HB, Vujanic GM, Taylor RE; United Kingdom Children's Cancer Study Group. Grundy RG, et al. Among authors: kelsey a. Pediatr Blood Cancer. 2004 Apr;42(4):311-9. doi: 10.1002/pbc.10477. Pediatr Blood Cancer. 2004. PMID: 14966826 Clinical Trial.
238 results